HALO

HALOZYME THERAPEUTICS INC

HALO·40637H109·US·Common Stock·Healthcare - Biotechnology-13D/G

HALO (HALOZYME THERAPEUTICS INC) is held by 242 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1B), VANGUARD CAPITAL MANAGEMENT LLC ($418.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($414.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 125 funds bought HALO.

242
Holders
(19 Elite)
$8.2B
Total Value
52% (241)
Consensus
125 buying - 116 selling
13F: Insider & Congress: Updated regularly
HALO

Smart Money Verdict

View all
Loading verdict
Held by 242 funds
19 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 8, 2026 · Activists Apr 30, 2026 · Congress Oct 12, 2026

InsiderTHTorley HelenExercise 20K shOct 8, 2026
InsiderTHTorley HelenSell $22KOct 8, 2026
InsiderTHTorley HelenSell $337KOct 8, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
13.3M(+0.1%)$1B0.0%+141.38%
32
Increased
5.4M(+1.5%)$418.8M0.0%+80.18%
32
Increased
5.3M(+0.9%)$414.8M0.0%+80.39%
31
Increased
5.2M(+4.9%)$405.4M0.0%+230.26%
33
Decreased
3.2M(-20.8%)$248.7M0.0%+139.18%
0
Increased
2.8M(+10.6%)$221.7M0.0%+91.45%
34
Increased
2.8M(+3.4%)$216.8M0.2%+90.52%
38
Decreased
2.7M(-5.9%)$214.5M0.0%+114.45%
0
Increased
2.5M(+0.6%)$197.3M0.0%+322.94%
31
Decreased
2.5M(-0.6%)$196.5M0.6%+75.46%
0
Increased
2.1M(+0.5%)$163.5M0.0%+164.09%
30
Increased
2M(+7.4%)$157M0.1%+79.84%
33
Increased
1.9M(+180.9%)$151.7M0.6%+68.70%
69
Increased
1.8M(+12.4%)$141.7M0.3%+87.73%
41
Decreased
1.7M(-11.1%)$133.4M0.1%+104.78%
0
Increased
1.7M(+4.3%)$129.4M0.1%+75.34%
32
Increased
1.5M(+63.3%)$116.8M0.0%+71.95%
44
Increased
1.5M(+1.8%)$116.7M0.3%+125.80%
37
Decreased
1.4M(-4.4%)$110.9M0.1%+122.10%
0
Decreased
1.7M(-2.3%)$109.6M0.0%+200.61%
0

Showing 1-20 of 254

1 / 13
HALOHALOHALOZYME THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used